Bellevue Group AG

Q4 2023 13F-HR Detailed Holdings

Location
Kuesnacht, V8
Holdings as of
12/31/2023
Date filed
2/14/2024
Form type
13F-HR
Num holdings
202
Total value ($000)
$6,537,470
Net value change ($000)
+330,558 (5.3%)
New positions
25
Sold out positions
18
Turnover %
2.1%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IMCR 65,654 6374.2%
ARVN 61,479 147.3%
Intra-Cellular Therapies, Inc. 54,478 33.0%
MGNX 50,068 109.6%
DXCM 49,513 77.4%
BHVN 46,010 NEW
BSX 43,569 31.2%
CLDX 43,542 83.3%
GEHC 40,529 4762.5%
ISRG 38,389 15.8%
Top Reduces (Value $000, Stocks/ETFs)
ARGX -117,460 -26.2%
UNH -57,451 -44.1%
VRTX -49,061 -14.1%
HUM -36,734 -44.4%
JAZZ -34,460 -100.0%
IQV -28,629 -93.7%
Shockwave Medical, Inc. -26,843 -53.0%
ELV -24,885 -32.9%
EVH -21,616 -21.6%
MOH -18,899 -36.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408